KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Other Non-Current Assets: 2010-2024

Historic Other Non-Current Assets for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to $130,000.

  • TherapeuticsMD's Other Non-Current Assets rose 710.34% to $470,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $470,000, marking a year-over-year increase of 710.34%. This contributed to the annual value of $130,000 for FY2024, which is 62.21% down from last year.
  • Per TherapeuticsMD's latest filing, its Other Non-Current Assets stood at $130,000 for FY2024, which was down 62.21% from $344,000 recorded in FY2023.
  • TherapeuticsMD's 5-year Other Non-Current Assets high stood at $48.7 million for FY2021, and its period low was $130,000 during FY2024.
  • In the last 3 years, TherapeuticsMD's Other Non-Current Assets had a median value of $253,000 in 2022 and averaged $242,333.
  • Per our database at Business Quant, TherapeuticsMD's Other Non-Current Assets plummeted by 99.54% in 2020 and then soared by 19,149.80% in 2021.
  • TherapeuticsMD's Other Non-Current Assets (Yearly) stood at $253,000 in 2020, then spiked by 19,149.80% to $48.7 million in 2021, then slumped by 99.48% to $253,000 in 2022, then skyrocketed by 35.97% to $344,000 in 2023, then plummeted by 62.21% to $130,000 in 2024.